Incretin-based medications—developed based on the therapeutic potential of GLP-1—are now highly effective, widely recommended treatments for type 2 diabetes and obesity complicated by comorbidities.
What comes next? Find out: spkl.io/6014Aa3g8
Thread
Nenhum Voo ainda